Massive study launches to map the course of rare genetic epilepsies
NCT ID NCT07413211
Summary
This study aims to collect detailed information on children and adults with genetic developmental and epileptic encephalopathies (DEEs), including a specific condition called MEF2C Haploinsufficiency Syndrome. It is not testing a treatment. Instead, researchers will track changes in development, seizures, communication, and behavior over time through in-person visits, virtual check-ins, or online surveys. The goal is to create a deep understanding of these conditions to help design better future clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEF2C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.